https://www.pharmiweb.com/press-release/2023-01-19/servier-and-taiho-oncology-present-overall-survival-data-for-trifluridinetipiracil-lonsurf-in-combination-with-bevacizumab-in-patients-with-refractory-metastatic-colorectal-cancer-at-2023-asco-gastrointestinal-cancers-symposium
0
0
1/19/23 at 9:29am
Organization
PharmiWeb.com
Author
PharmiWeb.Jobs
Patients treated with the investigational combination of trifluridine/tipiracil in combination with bevacizumab in the pivotal Phase 3 SUNLIGHT trial achieved clinically meaningful improvement in overall survival compared to trifluridine/tipiracil aloneResult…
Create an account
or login to join the discussion